fbpx Russ Havranek - Plus Therapeutics (PSTV)

Team Member

Russ Havranek, MS MBA

Vice President, Corporate Strategy and New Product Planning

Russ Havranek is the Vice President of Corporate Strategy and New Product Planning at Plus Therapeutics, Inc.  He was previously Vice President of Global Marketing and Business Development at Cytori Therapeutics.

Mr. Havranek has over 26 years of leadership experience developing and commercializing diagnostic and therapeutic products at global, publicly traded, biopharma and medical device companies. His prior roles in marketing, strategy, business development, general management, and R&D focused on the oncology, rare disease, cardiology, and orthopedic markets.  These roles were held at Johnson & Johnson, Guidant (now Abbott), Genentech (now Roche), DJO Global (now Enovis), Volcano (now Philips), and CareFusion (now Becton Dickinson).

Mr. Havranek received a MBA in Marketing from the Haas School of Business at the University of California, Berkeley, a MS in Bioengineering from Clemson University, and a BS in Biomedical Engineering from Northwestern University.